RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Arlington, TX · Cypress, TX · Dallas, TX · +119 more sites
Psoriasis clinical trials in San Antonio, TX
8 recruiting psoriasis studies with a site in San Antonio, TX.
RecruitingPhase 2NCT07801495
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Sponsor: Novartis Pharmaceuticals
Colleyville, TX · San Antonio, TX · +1 more sites
RecruitingPhase 3NCT07362017
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Sponsor: Vanda Pharmaceuticals
San Antonio, TX · Webster, TX · +8 more sites
RecruitingPhase 3NCT07250802
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Sponsor: Takeda
Bellaire, TX · San Antonio, TX · +9 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites
RecruitingPhase 3NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
San Antonio, TX · Southlake, TX · +45 more sites
RecruitingPhase 2NCT07489885
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Sponsor: InventisBio Co., Ltd
San Antonio, TX · +19 more sites
RecruitingPhase 2NCT06865105
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Sponsor: AbbVie
Austin, TX · Houston, TX · San Antonio, TX · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.